Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature

Affiliations

¹ 3rd Department of Medical Oncology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece. Electronic address: nmiaris@gmail.com.
² Department of Neurology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece.
³ Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
⁴ 3rd Department of Medical Oncology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece.

Review

Nikolaos Miaris et al. Clin Genitourin Cancer. 2017 Feb.

. 2017 Feb;15(1):e99-e103.

doi: 10.1016/j.clgc.2016.08.005. Epub 2016 Aug 10.

¹ 3rd Department of Medical Oncology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece. Electronic address: nmiaris@gmail.com.
² Department of Neurology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece.
³ Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
⁴ 3rd Department of Medical Oncology, "Agii Anargiri" General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greece.

No abstract available

Keywords: Anti-VEGF agents; Proteinuria; Renal carcinoma; Reversible posterior leukoencephalopathy syndrome; Tyrosine kinase inhibitors.

Publication types